Cargando…
CD271(+) Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model
Background: Ventricular arrhythmias (VA) are a common cause of sudden death after myocardial infarction (MI). Therefore, developing new therapeutic methods for the prevention and treatment of VA is of prime importance. Methods: Human bone marrow derived CD271(+) mesenchymal stem cells (MSC) were tes...
Autores principales: | Sadraddin, Haval, Gaebel, Ralf, Skorska, Anna, Lux, Cornelia Aquilina, Sasse, Sarah, Ahmad, Beschan, Vasudevan, Praveen, Steinhoff, Gustav, David, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953053/ https://www.ncbi.nlm.nih.gov/pubmed/31757119 http://dx.doi.org/10.3390/cells8121474 |
Ejemplares similares
-
The Effects of Hypoxic Preconditioned Murine Mesenchymal Stem Cells on Post-Infarct Arrhythmias in the Mouse Model
por: Ahmad, Beschan, et al.
Publicado: (2022) -
Angiogenic Potential of Bone Marrow Derived CD133(+) and CD271(+) Intramyocardial Stem Cell Trans- Plantation Post MI
por: Sasse, Sarah, et al.
Publicado: (2019) -
Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells
por: Lemcke, Heiko, et al.
Publicado: (2017) -
Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice
por: Zarniko, Nicole, et al.
Publicado: (2020) -
Cardiomyocyte Transplantation after Myocardial Infarction Alters the Immune Response in the Heart
por: Vasudevan, Praveen, et al.
Publicado: (2020)